Anika Therapeutics grants 2,500 non-statutory stock options at $9.15.
PorAinvest
viernes, 5 de septiembre de 2025, 5:04 am ET1 min de lectura
ANIK--
The stock options vest over three years, with one-third vesting annually. The options will expire after ten years and are subject to the terms and conditions outlined in the equity award agreement approved by Anika. The grant was made in compliance with Nasdaq Listing Rule 5635(c)(4), which requires companies to disclose material inducements to employment as part of their compensation packages.
Anika Therapeutics, Inc. is committed to delivering and advancing osteoarthritis pain management and orthopedic regenerative solutions. The company's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
References:
[1] https://www.marketscreener.com/news/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-ce7d59d9d889f42d
[2] https://www.globenewswire.com/news-release/2025/09/05/3145141/28467/en/Anika-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
[3] https://www.stocktitan.net/news/ANIK/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-1f04vu2xj6eu.html
Anika Therapeutics granted non-statutory stock options covering 2,500 shares of common stock to a newly hired non-executive employee at a per share exercise price of $9.15. The grant was made under the Anika Therapeutics, Inc. 2021 Inducement Plan and was approved by the compensation committee of the board of directors. The grant was a material inducement to the employee's acceptance of employment.
Anika Therapeutics, Inc. (NASDAQ: ANIK), a leading player in osteoarthritis pain management and regenerative solutions, has granted non-statutory stock options to a newly hired non-executive employee. The grant, made on September 2, 2025, covers 2,500 shares of common stock at a per share exercise price of $9.15. The grant was executed under the Anika Therapeutics, Inc. 2021 Inducement Plan and was approved by the compensation committee of the board of directors. This move was a material inducement to the employee's acceptance of employment with Anika.The stock options vest over three years, with one-third vesting annually. The options will expire after ten years and are subject to the terms and conditions outlined in the equity award agreement approved by Anika. The grant was made in compliance with Nasdaq Listing Rule 5635(c)(4), which requires companies to disclose material inducements to employment as part of their compensation packages.
Anika Therapeutics, Inc. is committed to delivering and advancing osteoarthritis pain management and orthopedic regenerative solutions. The company's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
References:
[1] https://www.marketscreener.com/news/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-ce7d59d9d889f42d
[2] https://www.globenewswire.com/news-release/2025/09/05/3145141/28467/en/Anika-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
[3] https://www.stocktitan.net/news/ANIK/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-1f04vu2xj6eu.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios